Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Neobo Fastigheter in connection with the listing of Neobo Fastigheter’s shares on Nasdaq First North Premier
Mandate

Vinge has advised Neobo Fastigheter in connection with the listing of Neobo Fastigheter’s shares on Nasdaq First North Premier

February 10, 2023 Capital Markets and Public M&A Corporate Tax

Vinge has advised Neobo Fastigheter AB (publ) (”Neobo”) in connection with the listing of Neobo’s shares on Nasdaq First North Premier. The company description was published on 6 February 2023 and the first day of trading on Nasdaq First North Premier was on 10 February 2023.

Neobo is a property company that long-term manages and refines rental properties all over Sweden. The property portfolio consists of 8,381 apartments distributed over 268 properties, with a total property value of SEK 15.3 billion as of 31 December 2022. The company’s business model is to manage and refine residential properties in municipalities with population growth, good employment rate and a stable rental market.

Vinge’s team consisted of Jesper Schönbeck, Rikard Lindahl, Joel Magnusson, Johannes Akyol, Gabriel Chabo, Clara Sohlberg, Kristoffer Larson, Victor Ericsson and Maria Schultzberg.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025